Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain

News | Molecular Imaging

Molecular Imaging Offers Insight Into Chemo-brain

March 29, 2023 — A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate ...

March 29, 2023

Collaboration to develop a Granzyme B-targeted agent for PET imaging applications in inflammation and cancer indications

News | PET Imaging

Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck

March 29, 2023 — Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to ...

March 29, 2023

Getz Healthcare announced that it has partnered with Subtle Medical, a Menlo Park, CA-based healthcare technology company, to distribute the company's artificial intelligence (AI)-based software solutions for faster and safer medical imaging.

News | Artificial Intelligence

Subtle Medical Partners with Getz Healthcare to Improve Medical Imaging with AI-powered Technology

March 29, 2023 — In a partnership which aims to provide faster and safer medical imaging across Australia and New ...

March 29, 2023

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging

News | Molecular Imaging

JNM Explores Potential Applications for ChatGPT in Nuclear Medicine and Molecular Imaging

March 28, 2023 — A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an ...

March 28, 2023

News | PET Imaging

Nuclidium and University Hospital Basel Receive NETRF Investigator Award to Initiate Phase 1 Trial with Novel Copper-based Radiotheranostic Program TraceNET in Neuroendocrine Tumors

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

March 24, 2023

A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very fine resolution has been developed and successfully tested, according to research published in the March issue of The Journal of Nuclear Medicine.

News | Nuclear Imaging

New Compact and Low-cost Lensless Radiomicroscope Developed for Nuclear Medicine Imaging

March 22, 2023 — A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very ...

March 22, 2023

Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical services, is pleased to announce that it has executed a Clinical Study/Research Agreement with Ochsner Clinic Foundation

News | PET-CT

Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device

March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical ...

March 21, 2023

RYZ101 positioned to be the first approved Actinium-225 radiopharmaceutical therapy for the industry

News | Radiopharmaceuticals and Tracers

RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101 (Actinium-225 DOTATATE) in Neuroendocrine Tumors

March 20, 2023 — RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against ...

March 20, 2023

A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients

News | Radiopharmaceuticals and Tracers

Pluvicto Supply Shortage Update: What SNMMI is Doing

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to ...

March 16, 2023

Researchers found evidence of heart muscle inflammation in a small number of patients with acute myocarditis after COVID-19 vaccination, but not in patients without acute myocarditis

News | Coronavirus (COVID-19)

Study Examines Heart Inflammation after COVID Vaccine

March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...

March 10, 2023

Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP‑001

News | Contrast Media

New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care

March 9, 2023 — Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate ...

March 09, 2023

100-foot crane lifting Rhodotron TTE-300 HE Electron Beam Accelerator at NorthStar Medical Radioisotope's new Ac-225 Production facility in Beloit, Wisconsin (Photo: Business Wire)

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)

March 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

March 03, 2023

Novel manganese-based macrocyclic Magnetic Resonance Imaging (MRI) agent could offer an alternative to gadolinium-based agents

News | Contrast Media

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

March 2, 2023 — GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion ...

March 02, 2023

Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT solution - Philips Spectral Angio CT suite

News | SPECT-CT

Philips Announces New Milestones in the Development of the World’s First Spectral Detector Angio CT Solution

March 2, 2023 —Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT ...

March 02, 2023

Sponsored Content | Videos | Contrast Media

VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

February 27, 2023

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for somatostatin receptor (SSTR) PET imaging for patients with neuroendocrine tumors (NETs).

News | PET Imaging

Procedure Standard/practice Guideline Published for SSTR PET Imaging of Neuroendocrine Tumors

February 23, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of ...

February 23, 2023

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital in China

News | Radiation Therapy

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...

February 16, 2023

First dosage administered at the Hospital of the University of Pennsylvania following FDA approval

News | Contrast Media

Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

February 16, 2023

The FDA has identified this as a Class I recall, the most serious type of recall

News | Nuclear Imaging

GE HealthCare Recalls Nuclear Medicine 600/800 Series Systems for Risk of Detector Fall That May Injure Patients

February 23, 2023 — Editor's note: This news item has been updated to reflect that the FDA has since updated its alert ...

February 15, 2023

Requiring half the gadolinium dosage compared to other macrocyclic gadolinium-based contrast agents (GBCAs) in approved indications in the U.S., gadopiclenol also has the highest relaxivity compared to approved GBCAs1-7

News | Contrast Media

First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI

February 15, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

February 15, 2023